PR Newswire Asia's news > Biotechnology

< Previous page

All Airlines/Aviation Auto Maritime/Shipbuilding Transportation Computer Hardware Computer Networks Computer Software Computer/Electronics Electronic Commerce Electronic Components High Tech Security Internet Technology Peripherals Semiconductors Electronics Gaming Consumer Electronics Mobile Entertainment Multimedia/Online/Internet Telecommunications Household/Consumer/Cosmetics Retail Supermarkets Toys Alternative Energies Chemical Mining/Metals Oil/Energy Environmental Products & Services Green Technology Art Cosmetics & Personal Care Entertainment Fashion Film & Motion Picture Jewelry Banking/Financial Service Insurance Workforce Management/Human Resources Education Higher Education Biotechnology Health Care/Hospital Infectious Disease Control Medical Equipment Medical/Pharmaceuticals Agriculture Machinery Paper/Forest Products/Containers Textiles Domestic policy Legal issues Sports Hotels and Resorts Leisure/Travel/Hotels Travel Restaurants Beer, Wine & Spirits Beverages Non-Alcoholic Beverages Food/Beverages Advertising Books Music Publishing/Information Service Television Trade show news Real Estate Construction/Building Furniture & Furnishings  |   Title only   |   Print

Next page >

88IV - PR Newswire Asia's news - Biotechnology 5 RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. ... 2026-08-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Telix to Host R&D Day in New York City on September 22, 2026 MELBOURNE, Australia and INDIANAPOLIS , Aug. 6, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will host a Research and Development ... 2026-08-06T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-08-05T    Banking/Financial Service   Biotechnology   Computer/Electronics  Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization CRANBURY, N.J. and SUZHOU,China , Aug. 5, 2026 /PRNewswire/ -- Recently, Porton Advanced Solutions Ltd. ("Porton Advanced") has officially been granted a Drug Manufacturing License (Class C) ... 2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product Alteogen grants exclusive rights to develop and commercialize a subcutaneous biologic product using Hybrozyme ™ -based hyaluronidase ALT-B4 Alteogen is eligible to receive up to US$365 million, including ... 2026-08-05T    Biotechnology   Health Care/Hospital  Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea Advanced Capsule Technology for Improved Digestive Enzyme Delivery ... 2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Everest Medicines to Announce 2026 Interim Results and Host Online Investor Call on August 19, 2026 SHANGHAI , Aug. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026 Earnings Conference Call to be Held on August 20, 2026 ... 2026-08-05T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals  NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing SAN DIEGO , Aug. 5, 2026 /PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused ... 2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  72 patient multi-indication trial approved to fast track TRP-8803 commercialisation Human Research Ethics Committee (HREC) approval secured for world-first phase 1b/2a 8-indication basket study across in 72-patients of TRP-8803 Study will evaluate TRP-8803 (IV-infused psilocin) across ... 2026-08-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals
< Previous page	Next page >